Effects of Smoking and Smoking Cessation on Endothelial Function 1-Year Outcomes From a Randomized Clinical Trial

被引:143
|
作者
Johnson, Heather M. [1 ]
Gossett, Linda K. [1 ]
Piper, Megan E. [1 ]
Aeschlimann, Susan E. [1 ]
Korcarz, Claudia E. [1 ]
Baker, Timothy B. [1 ]
Fiore, Michael C. [1 ]
Stein, James H. [1 ]
机构
[1] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI 53792 USA
关键词
clinical trial; endothelial dysfunction; risk factors; smoking; SUSTAINED-RELEASE BUPROPION; RECEPTOR PARTIAL AGONIST; INTIMA-MEDIA THICKNESS; HEALTHY-YOUNG ADULTS; BRACHIAL-ARTERY; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; METABOLIC SYNDROME; CIGARETTE-SMOKING; PROGENITOR CELLS;
D O I
10.1016/j.jacc.2010.03.002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives The purpose of this study was to determine whether smoking cessation improves flow-mediated dilation (FMD) of the brachial artery. Background The long-term effects of continued smoking and smoking cessation on endothelial function have not been described previously. Methods This was a 1-year, prospective, double-blind, randomized, placebo-controlled clinical trial of the effects of 5 smoking cessation pharmacotherapies. FMD was measured by B-mode ultrasonography before and 1 year after the target smoking cessation date. Cessation was verified by exhaled carbon monoxide levels. Delta FMD was compared among study arms and between subjects who successfully quit smoking and those who continued to smoke. Predictors of baseline FMD and Delta FMD were identified by multivariable regression. Results The 1,504 current smokers (58% female, 84% white) were 44.7 +/- 11.1 years of age and smoked 21.4 +/- 8.9 cigarettes/day. Baseline FMD was similar in each treatment arm (p = 0.499) and was predicted by BA diameter (p < 0.001), reactive hyperemia blood flow (p < 0.001), high-density lipoprotein cholesterol (p = 0.001), and carbon monoxide (p = 0.012) levels. After 1 year, 36.2% quit smoking. FMD increased by 1% (6.2 +/- 4.4% to 7.2 +/- 4.2%) after 1 year (p = 0.005) in those who quit, but did not change (p = 0.643) in those who continued to smoke. Improved FMD among quitters remained significant (p = 0.010) after controlling for changes in brachial artery diameter, reactive hyperemia, low-density lipoprotein cholesterol, and the presence of a home smoking ban. Conclusions Despite weight gain, smoking cessation leads to prolonged improvements in endothelial function, which may mediate part of the reduced cardiovascular disease risk observed after smoking cessation. (Smoking Cessation Medications: Efficacy, Mechanisms and Algorithms; NCT00332644) (J Am Coll Cardiol 2010;55:1988-95) (C) 2010 by the American College of Cardiology Foundation
引用
收藏
页码:1988 / 1995
页数:8
相关论文
共 50 条
  • [1] EFFECTS OF SMOKING AND SMOKING CESSATION ON ENDOTHELIAL FUNCTION: ONE-YEAR OUTCOMES FROM A RANDOMIZED CLINICAL TRIAL
    Gossett, Linda K.
    Piper, Megan E.
    Johnson, Heather M.
    Aeschlimann, Susan E.
    Korcarz, Claudia E.
    Baker, Timothy B.
    Fiore, Michael C.
    Stein, James H.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (10)
  • [2] Effects of Smoking and Smoking Cessation on Lipids and Lipoproteins: Outcomes from a Randomized Clinical Trial
    Gepner, Adam D.
    Piper, Megan E.
    Johnson, Heather M.
    Fiore, Michael C.
    Baker, Timothy B.
    Stein, James H.
    [J]. CIRCULATION, 2010, 122 (21)
  • [3] Effects of smoking and smoking cessation on lipids and lipoproteins: Outcomes from a randomized clinical trial
    Gepner, Adam D.
    Piper, Megan E.
    Johnson, Heather M.
    Fiore, Michael C.
    Baker, Timothy B.
    Stein, James H.
    [J]. AMERICAN HEART JOURNAL, 2011, 161 (01) : 145 - 151
  • [4] Changes in breathomics from a 1-year randomized smoking cessation trial of electronic cigarettes
    Campagna, Davide
    Cibella, Fabio
    Caponnetto, Pasquale
    Amaradio, Maria Domenica
    Caruso, Massimo
    Morjaria, Jaymin B.
    Malerba, Mario
    Polosa, Riccardo
    [J]. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2016, 46 (08) : 698 - 706
  • [5] Lung function and respiratory symptoms in a 1-year randomized smoking cessation trial of varenicline in COPD patients
    Tashkin, D. P.
    Rennard, S.
    Hays, J. Taylor
    Lawrence, D.
    Marton, J. P.
    Lee, T. C.
    [J]. RESPIRATORY MEDICINE, 2011, 105 (11) : 1682 - 1690
  • [6] Long-Term Effects of Smoking and Smoking Cessation on Exercise Stress Testing: Three-Year Outcomes From a Randomized Clinical Trial
    Asthana, Asha
    Piper, Megan E.
    McBride, Patrick E.
    Ward, Ann
    Fiore, Michael C.
    Baker, Timothy B.
    Stein, James H.
    [J]. CIRCULATION, 2011, 124 (21)
  • [7] Long-term effects of smoking and smoking cessation on exercise stress testing: Three-year outcomes from a randomized clinical trial
    Asthana, Asha
    Piper, Megan E.
    McBride, Patrick E.
    Ward, Ann
    Fiore, Michael C.
    Baker, Timothy B.
    Stein, James H.
    [J]. AMERICAN HEART JOURNAL, 2012, 163 (01) : 81 - U110
  • [8] Evaluation of Post Cessation Weight Gain in a 1-Year Randomized Smoking Cessation Trial of Electronic Cigarettes
    Russo, Cristina
    Cibella, Fabio
    Caponnetto, Pasquale
    Campagna, Davide
    Maglia, Marilena
    Frazzetto, Evelise
    Mondati, Enrico
    Caruso, Massimo
    Polosa, Riccardo
    [J]. SCIENTIFIC REPORTS, 2016, 6
  • [9] Evaluation of Post Cessation Weight Gain in a 1-Year Randomized Smoking Cessation Trial of Electronic Cigarettes
    Cristina Russo
    Fabio Cibella
    Pasquale Caponnetto
    Davide Campagna
    Marilena Maglia
    Evelise Frazzetto
    Enrico Mondati
    Massimo Caruso
    Riccardo Polosa
    [J]. Scientific Reports, 6
  • [10] The effects of a smoking cessation intervention on 14.5-year mortality - A randomized clinical trial
    Anthonisen, NR
    Skeans, MA
    Wise, RA
    Manfreda, J
    Kanner, RE
    Connett, JE
    [J]. ANNALS OF INTERNAL MEDICINE, 2005, 142 (04) : 233 - 239